Field studies of cytotoxic T lymphocytes in malaria infections: Implications for malaria vaccine development

被引:33
作者
Aidoo, M [1 ]
Udhayakumar, V [1 ]
机构
[1] Ctr Dis Control & Prevent, Mol Vaccine Sect, Immunol Branch, Div Parasit Dis,Natl Ctr Infect Dis, Atlanta, GA 30341 USA
来源
PARASITOLOGY TODAY | 2000年 / 16卷 / 02期
关键词
D O I
10.1016/S0169-4758(99)01592-6
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The search for a cytotoxic T lymphocyte (CTL)-inducing malaria vaccine has moved forward from epitope identification to planning stages of safety and immunogenicity trials of candidate vaccines. Development of CTL-inducing vaccine candidates has taken center stage based on the observation that CTL-mediated protection might be the dominant mechanism by which sterile immunity is achieved in irradiated sporozoite immunization experiments in humans and laboratory animals. However; studies in naturally infected individuals living in endemic areas, as reviewed here by Michael Aidoo and Venkatachalam Udhayakumar, have revealed that CTL induction might be influenced by factors such as parasite variants, host genes, other infections and transmission patterns. The influence of these factors on CTL induction has been demonstrated individually and in various combinations in controlled animal experiments. However, in naturally infected humans, they are presented in a complex hos-parasite-environment interaction, in a manner that is not easily achieved in laboratory-based experiments. Understanding these interactions is crucial for the development and testing of CTL-inducing vaccines for humans.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 58 条
[1]   HELMINTH INFECTION RESULTS IN DECREASED VIRUS-SPECIFIC CD8+ CYTOTOXIC T-CELL AND TH1-CYTOKINE RESPONSES AS WELL AS DELAYED VIRUS CLEARANCE [J].
ACTOR, JK ;
SHIRAI, M ;
KULLBERG, MC ;
BULLER, RML ;
SHER, A ;
BERZOFSKY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :948-952
[2]   IDENTIFICATION OF CONSERVED ANTIGENIC COMPONENTS FOR A CYTOTOXIC T-LYMPHOCYTE-INDUCING VACCINE AGAINST MALARIA [J].
AIDOO, M ;
LALVANI, A ;
ALLSOPP, CEM ;
PLEBANSKI, M ;
MEISNER, SJ ;
KRAUSA, P ;
BROWNING, M ;
MORRISJONES, S ;
GOTCH, F ;
FIDOCK, DA ;
TAKIGUCHI, M ;
ROBSON, KJH ;
GREENWOOD, BM ;
DRUILHE, P ;
WHITTLE, HC ;
HILL, AVS .
LANCET, 1995, 345 (8956) :1003-1007
[3]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[4]  
BLUMTIROUVANZIAM U, 1995, J IMMUNOL, V154, P3922
[5]  
Daniel S, 1998, J IMMUNOL, V161, P617
[6]  
Denkers EY, 1997, J IMMUNOL, V159, P1903
[7]   Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8(+) T cell-, interferon gamma-, and nitric oxide-dependent immunity [J].
Doolan, DL ;
Sedegah, M ;
Hedstrom, RC ;
Hobart, P ;
Charoenvit, Y ;
Hoffman, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1739-1746
[8]   Degenerate cytotoxic T cell epitopes from P-falciparum restricted by multiple HLA-A and HLA-B supertype alleles [J].
Doolan, DL ;
Hoffman, SL ;
Southwood, S ;
Wentworth, PA ;
Sidney, J ;
Chesnut, RW ;
Keogh, E ;
Appella, E ;
Nutman, TB ;
Lal, AA ;
Gordon, DM ;
Oloo, A ;
Sette, A .
IMMUNITY, 1997, 7 (01) :97-112
[9]   Distinct T cell receptor signaling requirements for perforin- or FasL-mediated cytotoxicity [J].
Esser, MT ;
Krishnamurthy, B ;
Braciale, VL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1697-1706
[10]   EXPRESSION OF THE TERMINAL PROTEIN OF HEPATITIS-B VIRUS IS ASSOCIATED WITH FAILURE TO RESPOND TO INTERFERON THERAPY [J].
FOSTER, GR ;
GOLDIN, RD ;
HAY, A ;
MCGARVEY, MJ ;
STARK, GR ;
THOMAS, HC .
HEPATOLOGY, 1993, 17 (05) :757-762